You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Drugs for Osteoarthritis Pain Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Summary

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
In 2017, the global Drugs for Osteoarthritis Pain market size was 7440 million US$ and it is expected to reach 11600 million US$ by the end of 2025, with a CAGR of 5.7% between 2018 and 2025.

This report studies the Drugs for Osteoarthritis Pain market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into
Oral
Injection
External

Market segment by Application, the market can be split into
Medical Care
Personal Care

The study objectives of this report are:
To study and forecast the market size of Drugs for Osteoarthritis Pain in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Osteoarthritis Pain are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, LBIesearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Drugs for Osteoarthritis Pain market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents

Drugs for Osteoarthritis Pain Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Drugs for Osteoarthritis Pain
1.1 Drugs for Osteoarthritis Pain Market Overview
1.1.1 Drugs for Osteoarthritis Pain Product Scope
1.1.2 Market Status and Outlook
1.2 Global Drugs for Osteoarthritis Pain Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Drugs for Osteoarthritis Pain Market by Type
1.3.1 Oral
1.3.2 Injection
1.3.3 External
1.4 Drugs for Osteoarthritis Pain Market by End Users/Application
1.4.1 Medical Care
1.4.2 Personal Care

2 Global Drugs for Osteoarthritis Pain Competition Analysis by Players
2.1 Drugs for Osteoarthritis Pain Market Size (Value) by Players (2017 and 2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.3.5 Recent Developments
3.4 Bayer
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.4.5 Recent Developments
3.5 Eli Lilly
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.5.5 Recent Developments
3.6 Novartis
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.6.5 Recent Developments
3.7 Sanofi
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.7.5 Recent Developments
3.8 Horizon Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.8.5 Recent Developments
3.9 Abbott
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.9.5 Recent Developments
3.10 Mylan
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Drugs for Osteoarthritis Pain Revenue (Value) (2013-2018)
3.10.5 Recent Developments
3.11 Daiichi Sankyo
3.12 TEVA
3.13 Almatica Pharma
3.14 Astellas Pharma
3.15 Tide Pharmaceutical
3.16 Iroko Pharmaceuticals
3.17 Hengrui Pharmaceutical
3.18 Abiogen Pharma

4 Global Drugs for Osteoarthritis Pain Market Size by Type and Application (2013-2018)
4.1 Global Drugs for Osteoarthritis Pain Market Size by Type (2013-2018)
4.2 Global Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
4.3 Potential Application of Drugs for Osteoarthritis Pain in Future
4.4 Top Consumer/End Users of Drugs for Osteoarthritis Pain

5 North America Drugs for Osteoarthritis Pain Development Status and Outlook
5.1 North America Drugs for Osteoarthritis Pain Market Size (2013-2018)
5.2 North America Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

6 Europe Drugs for Osteoarthritis Pain Development Status and Outlook
6.1 Europe Drugs for Osteoarthritis Pain Market Size (2013-2018)
6.2 Europe Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

7 China Drugs for Osteoarthritis Pain Development Status and Outlook
7.1 China Drugs for Osteoarthritis Pain Market Size (2013-2018)
7.2 China Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

8 Rest of Asia Pacific Drugs for Osteoarthritis Pain Development Status and Outlook
8.1 Rest of Asia Pacific Drugs for Osteoarthritis Pain Market Size (2013-2018)
8.2 Rest of Asia Pacific Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

9 Central & South America Drugs for Osteoarthritis Pain Development Status and Outlook
9.1 Central & South America Drugs for Osteoarthritis Pain Market Size (2013-2018)
9.2 Central & South America Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

10 Middle East & Africa Drugs for Osteoarthritis Pain Development Status and Outlook
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2013-2018)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Drugs for Osteoarthritis Pain Market Size (Value) by Regions (2018-2025)
11.1.1 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.1.3 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.1.4 Rest of Asia Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.1.5 Central & South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.1.6 Middle East & Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2018-2025)
11.2 Global Drugs for Osteoarthritis Pain Market Size (Value) by Type (2018-2025)
11.3 Global Drugs for Osteoarthritis Pain Market Size by Application (2018-2025)

12 Drugs for Osteoarthritis Pain Market Dynamics
12.1 Drugs for Osteoarthritis Pain Market Opportunities
12.2 Drugs for Osteoarthritis Pain Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Drugs for Osteoarthritis Pain Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Drugs for Osteoarthritis Pain Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 105